Major Investor Liquidates Entire 7.5% Stake in Waldencast plc
WALD has more than doubled off its 52-week low of $0.72 on elevated volume (3.5× avg).
Summary
A major institutional investor, Beauty Ventures LLC, has liquidated its entire stake in Waldencast plc, disposing of over 9.3 million shares and 3.1 million warrants, representing a significant portion of the company.
Key Events · Ownership and Investor Activity · WALD
-
Major Shareholder Exit
Beauty Ventures LLC and Waldencast Long-Term Capital LLC have fully disposed of their holdings, including 9,309,200 Class A shares and 3,103,067 private placement warrants.
-
Significant Stake Liquidated
The disposed shares represent approximately 7.87% of the outstanding Class A shares and an estimated $14.09 million in value, or 7.52% of the company's market capitalization.
-
Fund Liquidation
The disposition was completed as part of the winding up and liquidation of Beauty Ventures LLC, transferring shares to its members.
-
Coincides with Strategic Changes
This complete exit by a major investor occurs shortly after Waldencast plc announced the sale of its Obagi Medical business for up to $460 million.
Analysis · WALD · Industrial Applications And Services
Beauty Ventures LLC, a significant institutional investor, has fully disposed of its 9.3 million Class A shares and 3.1 million warrants in Waldencast plc. This complete liquidation, representing approximately 7.5% of the company's market capitalization, signals a loss of conviction from a major shareholder. While stated as part of the fund's winding up, the timing coincides with recent strategic shifts at Waldencast, including the sale of its Obagi Medical business.
At the time of this filing, WALD was trading at $1.51 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $187.3M. The 52-week trading range was $0.72 to $3.22. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.